Who has invested in Slayback Pharma?

KKR, Everstone Group are named among the investors backing Slayback Pharma.

Slayback Pharma Funding: $110M Raised, Growth (2019)

Slayback Pharma funding overview

Slayback Pharma is based in Princeton, NJ. Slayback Pharma has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in January 2019. The round record for Slayback Pharma runs through 2019; nothing later has been disclosed. Investors on record include KKR, Everstone Group. 2 distinct backers are named across the disclosed rounds.

Slayback Pharma at a glance

Total raised: $110M
Latest round: Growth
Latest round date: January 2019
Headquarters: Princeton, NJ
Notable investors: KKR, Everstone Group

Frequently asked about Slayback Pharma funding

How much has Slayback Pharma raised?: Slayback Pharma has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Slayback Pharma?: KKR, Everstone Group are named among the investors backing Slayback Pharma.
What was the latest Slayback Pharma funding round?: The most recent disclosed round is a Growth, announced in January 2019.
Where is Slayback Pharma based?: Slayback Pharma is based in Princeton, NJ.
When did Slayback Pharma last raise?: The last disclosed Slayback Pharma round closed in January 2019 at Growth.

We update the Slayback Pharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Princeton and their backers are listed below.

Slayback Pharma Funding: $110M Raised, Growth (2019)

Slayback Pharma funding overview

Slayback Pharma at a glance

Frequently asked about Slayback Pharma funding

Companies related to Slayback Pharma (31)

Browse related funding lists (4)